Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $1.7 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 31.78% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 31.78% YoY) and the FY2025 annual result came in at $1.7 million, down 31.78% from the prior year.
• Non-Current Deferred Tax Liability steadied at $1.7 million in Q1 2026 per CATX's latest filing, from $1.7 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $4.6 million in Q4 2023 and troughed at $1.7 million in Q4 2025.
• A 4-year average of $3.2 million and a median of $2.5 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability plunged 45.67% in 2024, then tumbled 31.78% in 2025.
• Over 4 years, Non-Current Deferred Tax Liability stood at $4.6 million in 2023, then slumped by 45.67% to $2.5 million in 2024, then slumped by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $1.7 million, $1.7 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.